QuantHealth raises $45M to simulate clinical trials before patients enroll
QuantHealth, a Tel Aviv startup, has raised forty five million dollars in Series B funding to grow its clinical trial simulation platform. Qumra Capital led the round, and the company says total funding now stands near seventy million dollars since its 2020 founding. The pitch is simple to state and hard to achieve: test a trial in software before a single patient is recruited. QuantHealth's tools let drug developers model whether a protocol is likely to succeed, tune who gets included, and est
1 min